Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice

Katerina Dvorakova, Robert T Dorr, Alfred Gallegos, Thomas McClure, Garth Powis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Oryzalin [3,5-dinitro-N,N-di(n-propyl)benzensulfanilamide] is a widely used sulfonamide herbicide that selectively inhibits microtubule formation in algae and higher plants. Oryzalin has also been found to be an inhibitor of intracellular free Ca2+ signalling in mammalian cells and to have antitumor activity in animals. Despite its widespread use there have been no reports of the pharmacokinetics of oryzalin in animals or man. A reversed-phase high-performance liquid chromatographic (HPLC) method was developed to measure oryzalin in biological fluids. Following repeated daily administration of oryzalin to mice by the i.p. route at 200 mg/kg, or the p.o. route at 300 mg/kg, peak plasma concentrations of up to 25 μg/ml were achieved. The half life for oryzalin in plasma of mice given i.p. oryzalin was 14.3 h with a clearance of 0.07 l/h. A major metabolite of oryzalin, N-depropyloryzalin, was identified in plasma and its structure confirmed by mass spectral analysis (M+H+=305). This metabolite was cleared more rapidly than oryzalin with a half life of 1.15 h and a clearance of 0.17 l/h. N-Depropyloryzalin caused similar inhibition of colony formation by HT-29 colon cancer cells as oryzalin with IC50=8 μg/ml. The results suggest that oryzalin and its N-depropyl metabolite can inhibit tumor colony formation at pharmacologically achievable levels.

Original languageEnglish (US)
Pages (from-to)275-281
Number of pages7
JournalJournal of Chromatography B: Biomedical Applications
Volume696
Issue number2
DOIs
StatePublished - Aug 29 1997

Fingerprint

Pharmacokinetics
Herbicides
Metabolites
Plasmas
Animals
oryzalin
Cells
Sulfonamides
Algae
Spectrum analysis
Tumors

Keywords

  • Oryzalin

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice. / Dvorakova, Katerina; Dorr, Robert T; Gallegos, Alfred; McClure, Thomas; Powis, Garth.

In: Journal of Chromatography B: Biomedical Applications, Vol. 696, No. 2, 29.08.1997, p. 275-281.

Research output: Contribution to journalArticle

Dvorakova, Katerina ; Dorr, Robert T ; Gallegos, Alfred ; McClure, Thomas ; Powis, Garth. / Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice. In: Journal of Chromatography B: Biomedical Applications. 1997 ; Vol. 696, No. 2. pp. 275-281.
@article{96cddf3414514bb390350460c171b516,
title = "Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice",
abstract = "Oryzalin [3,5-dinitro-N,N-di(n-propyl)benzensulfanilamide] is a widely used sulfonamide herbicide that selectively inhibits microtubule formation in algae and higher plants. Oryzalin has also been found to be an inhibitor of intracellular free Ca2+ signalling in mammalian cells and to have antitumor activity in animals. Despite its widespread use there have been no reports of the pharmacokinetics of oryzalin in animals or man. A reversed-phase high-performance liquid chromatographic (HPLC) method was developed to measure oryzalin in biological fluids. Following repeated daily administration of oryzalin to mice by the i.p. route at 200 mg/kg, or the p.o. route at 300 mg/kg, peak plasma concentrations of up to 25 μg/ml were achieved. The half life for oryzalin in plasma of mice given i.p. oryzalin was 14.3 h with a clearance of 0.07 l/h. A major metabolite of oryzalin, N-depropyloryzalin, was identified in plasma and its structure confirmed by mass spectral analysis (M+H+=305). This metabolite was cleared more rapidly than oryzalin with a half life of 1.15 h and a clearance of 0.17 l/h. N-Depropyloryzalin caused similar inhibition of colony formation by HT-29 colon cancer cells as oryzalin with IC50=8 μg/ml. The results suggest that oryzalin and its N-depropyl metabolite can inhibit tumor colony formation at pharmacologically achievable levels.",
keywords = "Oryzalin",
author = "Katerina Dvorakova and Dorr, {Robert T} and Alfred Gallegos and Thomas McClure and Garth Powis",
year = "1997",
month = "8",
day = "29",
doi = "10.1016/S0378-4347(97)00261-2",
language = "English (US)",
volume = "696",
pages = "275--281",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "0378-4347",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice

AU - Dvorakova, Katerina

AU - Dorr, Robert T

AU - Gallegos, Alfred

AU - McClure, Thomas

AU - Powis, Garth

PY - 1997/8/29

Y1 - 1997/8/29

N2 - Oryzalin [3,5-dinitro-N,N-di(n-propyl)benzensulfanilamide] is a widely used sulfonamide herbicide that selectively inhibits microtubule formation in algae and higher plants. Oryzalin has also been found to be an inhibitor of intracellular free Ca2+ signalling in mammalian cells and to have antitumor activity in animals. Despite its widespread use there have been no reports of the pharmacokinetics of oryzalin in animals or man. A reversed-phase high-performance liquid chromatographic (HPLC) method was developed to measure oryzalin in biological fluids. Following repeated daily administration of oryzalin to mice by the i.p. route at 200 mg/kg, or the p.o. route at 300 mg/kg, peak plasma concentrations of up to 25 μg/ml were achieved. The half life for oryzalin in plasma of mice given i.p. oryzalin was 14.3 h with a clearance of 0.07 l/h. A major metabolite of oryzalin, N-depropyloryzalin, was identified in plasma and its structure confirmed by mass spectral analysis (M+H+=305). This metabolite was cleared more rapidly than oryzalin with a half life of 1.15 h and a clearance of 0.17 l/h. N-Depropyloryzalin caused similar inhibition of colony formation by HT-29 colon cancer cells as oryzalin with IC50=8 μg/ml. The results suggest that oryzalin and its N-depropyl metabolite can inhibit tumor colony formation at pharmacologically achievable levels.

AB - Oryzalin [3,5-dinitro-N,N-di(n-propyl)benzensulfanilamide] is a widely used sulfonamide herbicide that selectively inhibits microtubule formation in algae and higher plants. Oryzalin has also been found to be an inhibitor of intracellular free Ca2+ signalling in mammalian cells and to have antitumor activity in animals. Despite its widespread use there have been no reports of the pharmacokinetics of oryzalin in animals or man. A reversed-phase high-performance liquid chromatographic (HPLC) method was developed to measure oryzalin in biological fluids. Following repeated daily administration of oryzalin to mice by the i.p. route at 200 mg/kg, or the p.o. route at 300 mg/kg, peak plasma concentrations of up to 25 μg/ml were achieved. The half life for oryzalin in plasma of mice given i.p. oryzalin was 14.3 h with a clearance of 0.07 l/h. A major metabolite of oryzalin, N-depropyloryzalin, was identified in plasma and its structure confirmed by mass spectral analysis (M+H+=305). This metabolite was cleared more rapidly than oryzalin with a half life of 1.15 h and a clearance of 0.17 l/h. N-Depropyloryzalin caused similar inhibition of colony formation by HT-29 colon cancer cells as oryzalin with IC50=8 μg/ml. The results suggest that oryzalin and its N-depropyl metabolite can inhibit tumor colony formation at pharmacologically achievable levels.

KW - Oryzalin

UR - http://www.scopus.com/inward/record.url?scp=0030886942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030886942&partnerID=8YFLogxK

U2 - 10.1016/S0378-4347(97)00261-2

DO - 10.1016/S0378-4347(97)00261-2

M3 - Article

C2 - 9323548

AN - SCOPUS:0030886942

VL - 696

SP - 275

EP - 281

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 0378-4347

IS - 2

ER -